Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001

On November 20, 2001, inhalational anthrax was confirmed in an elderly woman from rural Connecticut. To determine her exposure source, we conducted an extensive epidemiologic, environmental, and laboratory investigation. Molecular subtyping showed that her isolate was indistinguishable from isolates associated with intentionally contaminated letters. No samples from her home or community yielded Bacillus anthracis, and she received no first-class letters from facilities known to have processed intentionally contaminated letters. Environmental sampling in the regional Connecticut postal facility yielded B. anthracis spores from 4 (31%) of 13 sorting machines. One extensively contaminated machine primarily processes bulk mail. A second machine that does final sorting of bulk mail for her zip code yielded B. anthracis on the column of bins for her carrier route. The evidence suggests she was exposed through a cross-contaminated bulk mail letter. Such cross-contamination of letters and postal facilities has implications for managing the response to future B. anthracis–contaminated mailings.

[1]  Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001. , 2001, MMWR. Morbidity and mortality weekly report.

[2]  Tanja Popovic,et al.  Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings , 2002, Emerging infectious diseases.

[3]  M. Heller,et al.  Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001 , 2003, Emerging infectious diseases.

[4]  C. P. Quinn,et al.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. , 2001, Emerging infectious diseases.

[5]  Jerome Hauer,et al.  Anthrax as a biological weapon, 2002: updated recommendations for management. , 2002, JAMA.

[6]  L. Price,et al.  Multiple-Locus Variable-Number Tandem Repeat Analysis Reveals Genetic Relationships within Bacillus anthracis , 2000, Journal of bacteriology.

[7]  Sandra Romero-Steiner,et al.  Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. , 2002, Emerging infectious diseases.

[8]  Aponte Deborah A. Adams Gerald Jones Willie J. Anderson D Connor,et al.  Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. , 2001, MMWR. Morbidity and mortality weekly report.

[9]  Tanja Popovic,et al.  First Case of Bioterrorism-Related Inhalational Anthrax in the United States, Palm Beach County, Florida, 2001 , 2002, Emerging infectious diseases.

[10]  Tanja Popovic,et al.  Molecular Subtyping of Bacillus anthracis and the 2001 Bioterrorism-Associated Anthrax Outbreak, United States , 2002, Emerging infectious diseases.

[11]  Glenn F Webb,et al.  Mailborne transmission of anthrax: Modeling and implications , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  W S GOCHENOUR,et al.  PATHOLOGY OF EXPERIMENTAL RESPIRATORY ANTHRAX IN MACACA MULATTA. , 1963, British journal of experimental pathology.

[13]  Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001. , 2001, MMWR. Morbidity and mortality weekly report.

[14]  Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. , 2001, MMWR. Morbidity and mortality weekly report.

[15]  Paul Mead,et al.  Environmental Sampling for Spores of Bacillus anthracis , 2002, Emerging infectious diseases.

[16]  Tanja Popovic,et al.  Fatal inhalational anthrax in a 94-year-old Connecticut woman. , 2002, JAMA.